Your browser doesn't support javascript.
loading
The Assessment of the Efficacy and Safety of Favipiravir for Patients with SARS-CoV-2 Infection: A Multicenter Non-randomized, Uncontrolled Single-arm Prospective Study.
Yanagisawa, Kunio; Takara, Katsuhiko; Suga, Hiroyuki; Saito, Akio; Hayashi, Toshimasa; Igarashi, Tsuneo; Tomizawa, Sachi; Saito, Etsuko; Sumiyoshi, Hisako; Ohyama, Yoshiaki; Tokue, Yutaka; Nakamura, Tetsuya.
Afiliación
  • Yanagisawa K; Infection Control and Prevention Center, Gunma University Hospital, Japan.
  • Takara K; Division of Nephrology, Fukaya Red Cross Hospital, Japan.
  • Suga H; Department of Pharmacy, Fukaya Red Cross Hospital, Japan.
  • Saito A; Division of Hematology, National Hospital Organization Shibukawa Medical Center, Japan.
  • Hayashi T; Division of Infectious Diseases, Japanese Red Cross Maebashi Hospital, Japan.
  • Igarashi T; Division of Pediatrics, National Hospital Organization Takasaki General Medical Center, Japan.
  • Tomizawa S; Clinical Investigation and Research Unit, Gunma University Hospital, Japan.
  • Saito E; Clinical Investigation and Research Unit, Gunma University Hospital, Japan.
  • Sumiyoshi H; Clinical Investigation and Research Unit, Gunma University Hospital, Japan.
  • Ohyama Y; Clinical Investigation and Research Unit, Gunma University Hospital, Japan.
  • Tokue Y; Infection Control and Prevention Center, Gunma University Hospital, Japan.
  • Nakamura T; Clinical Investigation and Research Unit, Gunma University Hospital, Japan.
Intern Med ; 61(21): 3197-3204, 2022 Nov 01.
Article en En | MEDLINE | ID: mdl-35945028

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2022 Tipo del documento: Article País de afiliación: Japón